ATNM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ATNM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-10), Actinium Pharmaceuticals's current share price is $7.96. Actinium Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.39. Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.25.
The historical rank and industry rank for Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Actinium Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 2.53. The lowest was 0.79. And the median was 1.36.
ATNM's Cyclically Adjusted PB Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Actinium Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was $1.492. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.39 for the trailing ten years ended in Mar. 2024.
The historical data trend for Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Actinium Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 1.70 | 1.33 | 1.05 | 0.89 | 1.23 |
For the Biotechnology subindustry, Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 7.96 | / | 6.39 | |
= | 1.25 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Actinium Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Actinium Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 1.492 | / | 131.7762 | * | 131.7762 | |
= | 1.492 |
Current CPI (Mar. 2024) = 131.7762.
Actinium Pharmaceuticals Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 4.706 | 100.560 | 6.167 |
201409 | 2.402 | 100.428 | 3.152 |
201412 | -1.925 | 99.070 | -2.561 |
201503 | 13.817 | 99.621 | 18.277 |
201506 | 17.250 | 100.684 | 22.577 |
201509 | 16.385 | 100.392 | 21.507 |
201512 | 14.960 | 99.792 | 19.755 |
201603 | 13.394 | 100.470 | 17.567 |
201606 | 12.106 | 101.688 | 15.688 |
201609 | 8.944 | 101.861 | 11.571 |
201612 | 9.682 | 101.863 | 12.525 |
201703 | 6.758 | 102.862 | 8.658 |
201706 | 4.548 | 103.349 | 5.799 |
201709 | 6.820 | 104.136 | 8.630 |
201712 | 5.122 | 104.011 | 6.489 |
201803 | 5.914 | 105.290 | 7.402 |
201806 | 4.704 | 106.317 | 5.830 |
201809 | 3.145 | 106.507 | 3.891 |
201812 | 2.285 | 105.998 | 2.841 |
201903 | 1.345 | 107.251 | 1.653 |
201906 | 2.900 | 108.070 | 3.536 |
201909 | 1.810 | 108.329 | 2.202 |
201912 | 1.028 | 108.420 | 1.249 |
202003 | 0.518 | 108.902 | 0.627 |
202006 | 3.855 | 108.767 | 4.670 |
202009 | 3.344 | 109.815 | 4.013 |
202012 | 3.497 | 109.897 | 4.193 |
202103 | 3.675 | 111.754 | 4.333 |
202106 | 3.817 | 114.631 | 4.388 |
202109 | 3.644 | 115.734 | 4.149 |
202112 | 3.321 | 117.630 | 3.720 |
202203 | 3.109 | 121.301 | 3.377 |
202206 | 3.144 | 125.017 | 3.314 |
202209 | 2.826 | 125.227 | 2.974 |
202212 | 2.589 | 125.222 | 2.725 |
202303 | 2.223 | 127.348 | 2.300 |
202306 | 1.967 | 128.729 | 2.014 |
202309 | 1.590 | 129.860 | 1.613 |
202312 | 1.316 | 129.419 | 1.340 |
202403 | 1.492 | 131.776 | 1.492 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sandesh Seth | director | 300 E 93RD STREET, #20-B, NEW YORK NY 10128 |
Steve O'loughlin | officer: VP, Finance and Corporate Dev. | 955 HARTMAN RUN ROAD, MORGANTOWN WV 26507 |
Dale L. Ludwig | officer: Chief Scientific Officer | 21 FERNWOOD ROAD, ROCKAWAY NJ 07866-2028 |
Jeffrey W. Chell | director | 521 MANDALAY AVENUE #708, CLEARWATER BEACH FL 33767 |
Ajit Shetty | director | 643 ZEEDIJK, KNOKKE C9 8300 |
Anil Kapur | officer: Chief Commercial Officer | 275 MADISON AVE, SUITE 702, NEW YORK NY 10016 |
Nitya G. Ray | officer: Executive Vice President | 14 BAYBURY COURT, EAST HANOVER NJ 07936 |
Mark Stanley Berger | officer: Chief Medical Officer | 140 RIVERSIDE DRIVE, APT. 9K, NEW YORK NY 10024 |
Memorial Sloan-kettering Cancer Center | 10 percent owner | 1275 YORK AVE., NEW YORK NY 10065 |
Sergio Traversa | director | 138 CANTERBURY LN, BLUE BELL PA 19422 |
C. David Nicholson, | director | 103 CHILDS ROAD, BASKIN RIDGE NJ 07092 |
Kaushik J Dave | director, officer: President and CEO | 4 WATER STREET, EDISON NJ 08820 |
Richard I Steinhart | director | 125 ELM STREET, NEW CANAAN CT 06840 |
Ahlb Holdings, Llc | 10 percent owner | C/O MSKCC, 1275 YORK AVE., NEW YORK NY 10065 |
Actinium Holdings, Ltd. | 10 percent owner | C/O /O STERLING MANAGEMENT, LTD., P.O. BOX HM 29, HAMILTON HM CX D0 00000 |
From GuruFocus
By PRNewswire • 09-07-2023
By PRNewswire • 01-02-2024
By PRNewswire • 12-11-2023
By PRNewswire • 12-11-2023
By PRNewswire PRNewswire • 05-10-2023
By PRNewswire PRNewswire • 01-12-2023
By PRNewswire PRNewswire • 02-06-2023
By PRNewswire • 07-24-2023
By PRNewswire PRNewswire • 06-14-2023
By PRNewswire • 08-21-2023